Dispensed: What to expect out of biotech M&A, Medicare Advantage enrollment in 2020, and what comes next for the DNA-testing industry

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Welcome to Dispensed, Business Insider's weekly healthcare newsletter. This week, musings on the slowdown in genetics and dispatches from BIO.

Consumers aren’t flocking to send their spit into genetic testing companies in as high a numbers as the industry expected, an issue the industry has sounded the alarm on for the past six months.

Industry experts aren’t expecting that market to ever come back, forcing the companies to adopt new strategies. Here’s where the companies are betting the industry could go from here.I spoke with a group of biotech executives onstage Monday about what it takes to prove a new drug should be covered by insurers. TheyAndrew tuned into a discussion about biotech dealmaking.

The top dealmakers, from Centerview, JPMorgan and Raymond James, revealed the 4 areas of biotech that are ripe for takeovers in 2020, from drugs that harness the body’s immune system to more precise ways to take on cancer.a top investor at Pfizer’s $1 billion VC arm. She spoke about the 2 biggest mistakes startup biotechs make when trying to win her cash.

Some general observations: nobody’s cleared 100,000 members in Medicare Advantage yet, and I’ll be curious how long it takes for the startups to get there. Compared to the millions of members insurers like UnitedHealthcare and Humana have, the startups still have a lot of room to grow.We’ve gotten updates as well on the virus’s impact on healthcare workers in Wuhan.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Medicare Advantage enrollment 2020: Oscar, Bright, Devoted, Clover - Business InsiderVC-backed startups are all competing for customers in the red-hot Medicare Advantage market. Here's our first look at how Oscar, Devoted, and Bright stack up.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Health Hubs And Medicare Advantage Boost CVS HealthCVS Health said a big boost in enrollment in seniors signing up for Medicare Advantage plans and new “health hub” formats in its stores are helping boost profits.
Source: Forbes - 🏆 394. / 53 Read more »

Nevada culinary union, in spat with Sanders, says it won't endorse a candidateThe union&39;s non-endorsement comes before next Saturday&39;s Democratic caucus and following a disagreement with Sanders over Medicare For All.
Source: YahooNews - 🏆 380. / 59 Read more »

South African inflation to slow in 2020, central bank to cut rates again: Reuters pollSouth African inflation is expected to be lower in 2020 than previously forecast...
Source: Reuters - 🏆 2. / 97 Read more »

Robert Smith Promises a New Cure Album in 2020: 'We're Wrapping it Up Now'On the red carpet at Wednesday night's (Feb. 12) 2020 NME Awards, Smith swore that the follow-up to 2008's '4:13 Dream' is coming soon. thecure Juantrez1 thecure thecure 💪💪💪💪💪💪 Check out our new EP🔥🔥🔥 Love Therapy officialdeezire
Source: billboard - 🏆 112. / 63 Read more »

Roku Expects to Sustain Robust Revenue GrowthThe maker of streaming-media devices expects revenue to increase 42% in 2020 after posting 52% growth last year, fueled in part by an explosion of new streaming services.
Source: WSJ - 🏆 98. / 63 Read more »